MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...
Leverages Abbott's Market-Leading MULTI-LINK Stent Design and Cobalt Chromium Alloy for the Treatment of Iliac Artery Disease Expands Abbott's Offerings of Innovative Therapies for Treatment of ...
ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...